NCT02573428View on ClinicalTrials.gov

Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder

CompletedOBSERVATIONAL
Enrollment

389

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Autism Spectrum Disorders
Trial Locations (1)

44104

Cleveland Clinic Center for Autism, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT02573428 - Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter